Systematic review with meta‐analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease
Alimentary Pharmacology & Therapeutics · 2023-03 · 57 (6) · 635-652
DOI: 10.1111/apt.17370 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 10.01.2023. Verfasst von Nishani Jayasooriya und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, St George's Healthcare NHS Trust, St George's University, London, UK. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 155-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: School for Public Health Research.
Abstract (Originalsprache)
Background
The impact of diagnostic delay on the clinical course of inflammatory bowel disease (IBD) remains uncertain.
Aim
To perform a systematic review of time to diagnosis and the impact of delayed diagnosis on clinical outcomes in Crohn's disease (CD) and ulcerative colitis (UC).
Methods
We searched EMBASE and Medline from inception to 30th November 2022 for studies reporting diagnostic interval, from symptom onset to IBD diagnosis. We calculated the median, interquartile range (IQR) and pooled weighted median, of median diagnostic intervals of eligible studies. We defined delayed diagnosis as individuals above the 75th centile of longest time to diagnosis in each study. Using random effects meta‐analysis, we pooled odds ratios (ORs) with 95% confidence intervals (CI) for studies reporting clinical outcomes, according to delayed diagnosis.
Results
One hundred and one studies representing 112,194 patients with IBD (CD = 59,359; UC = 52,835) met inclusion criteria. The median of median times to diagnosis was 8.0 (IQR: 5.0–15.2) and 3.7 months (IQR: 2.0–6.7) in CD and UC, respectively. In high‐income countries, this was 6.2 (IQR: 5.0–12.3) and 3.2 months (IQR: 2.2–5.3), compared with 11.7 (IQR: 8.3–18.0) and 7.8 months (IQR: 5.2–21.8) in low‐middle‐income, countries, for CD and UC respectively. The pooled weighted median was 7.0 (95% CI: 3.0–26.4) and 4.6 (95% CI: 1.0–96.0) months, for CD and UC respectively. Eleven studies, representing 6164 patients (CD = 4858; UC = 1306), were included in the meta‐analysis that examined the impact of diagnostic delay on clinical outcomes. In CD, delayed diagnosis was associated with higher odds of stricturing (OR = 1.88; CI: 1.35–2.62), penetrating disease (OR = 1.64; CI: 1.21–2.20) and intestinal surgery (OR = 2.24; CI: 1.57–3.19). In UC, delayed diagnosis was associated with higher odds of colectomy (OR = 4.13; CI: 1.04–16.40).
Conclusion
Delayed diagnosis is associated with disease progression in CD, and intestinal surgery in both CD and UC. Strategies are needed to achieve earlier diagnosis of IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, St George's Healthcare NHS Trust, St George's University, London, UK.
- Institute of Infection and Immunity, St George's University, London, UK.
- School of Public Health, Imperial College London, London, UK.
- Department of Primary Care and Population Health, University College London, London, UK.
- Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark.
ORCID-Profile: Nishani Jayasooriya, Samantha Baillie, Jonathan Blackwell, Alex Bottle, Irene Petersen, Hanna Creese, Sonia Saxena, Richard C Pollok
Förderung
- School for Public Health Research
Zitieren
APA
Jayasooriya, N., Baillie, S., Blackwell, J., Bottle, A., Petersen, I., Creese, H., Saxena, S., Pollok, R. C., & POP-IBD study group (2023). Systematic review with meta‐analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 57(6), 635-652. https://doi.org/10.1111/apt.17370
Vancouver
Jayasooriya N, Baillie S, Blackwell J, Bottle A, Petersen I, Creese H, et al. Systematic review with meta‐analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 2023;57(6):635-652. doi:10.1111/apt.17370
BibTeX
@article{Jayasooriya2023,
author = {Jayasooriya, Nishani and Baillie, Samantha and Blackwell, Jonathan and Bottle, Alex and Petersen, Irene and Creese, Hanna and Saxena, Sonia and Pollok, Richard C and POP-IBD study group, POP-IBD study group},
title = {Systematic review with meta‐analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2023},
volume = {57},
number = {6},
pages = {635--652},
doi = {10.1111/apt.17370}
}
EUVIMED